Materials
The SART CORS database contains comprehensive data from >90% of all clinics performing assisted reproductive technology (ART) cycles in the United States. The data were collected through voluntary submission, verified by SART, and then reported to the Centers for Disease Control and Prevention in compliance with the Fertility Clinic Success Rate and Certification Act of 1992 (Public Law 102-493). The SART maintains HIPAA-compliant business associate agreements with reporting clinics. In 2004, after a contract change with the Centers for Disease Control and Prevention, SART gained access to the SART CORS data system for research purposes. The data in the SART CORS are validated annually, with select clinics having on-site visits for chart review based on an algorithm for clinic selection ( 8 ). During each visit, data reported by the clinic were verified with information recorded in patients’ charts ( 8 ). In 2012, records for 2,045 cycles at 35 clinics were randomly selected for full validation, along with 238 egg or embryo banking cycles. The full validation included a review of 1,318 cycles for which pregnancy was reported. Among the nondonor cycles, 331 were multiple-fetus pregnancies. Ten out of 11 data fields selected for validation were found to have discrepancy rates of ≤5%. The exception was the diagnosis field, which, depending on the diagnosis, had a discrepancy rate between 2.1% and 9.2% ( 8 ).
This study included patients aged 20 to 50 with a live twin delivery in the SART CORS database with cycles from 2012 to 2017. Cycles were excluded if there was a single embryo transfer, monochorionic gestation, use of a gestational carrier, or pregnancy after a transfer of an embryo created from a frozen oocyte. The initial dataset obtained included 55,272 pregnancies. A total of 24,536 pregnancies were excluded for unrecorded gravidity or parity, fetal weight data not recorded, gestational age data not recorded, recorded gestational age less than 23 weeks 0 days or greater than 41 weeks 6 days, or average fetal weight less than 250 grams or greater than 5500 grams. Data from the remaining 30,736 pregnancies were included in the primary analysis ( Figure 1 and Table 1 ). The SART CORS dataset contains data on the history of preterm delivery as a dichotomous variable but does not contain information on the number of prior preterm births or the degree of prematurity. This study was approved by the University of Southern California institutional review board (HS-16-00396) and the SART research committee. Figure 1 Flow diagram of included and excluded cycles Table 1 Baseline demographic and clinical characteristics. Demographics and clinical characteristics Nulliparous n = 14,470 Parous n = 16,266 P value Maternal age (SD) 34.8 (5.1) 35.3 (4.7) <.01 Maternal BMI kg/m 2 (SD) ∗ 25.8 (5.7) 25.9 (5.6) Maternal BMI kg/m 2 [IQR] ∗ 24.4 [21.8, 28.5] 24.6 [21.8, 28.7] .02 Fetal sex Female/female, n (%) 3,443 (23.8) 4,164 (25.6) <.01 Female/male † , n (%) 7,285 (50.3) 7,686 (47.3) Male/male, n (%) 3,742 (25.9) 4,416 (27.1) Parity 0 1.4 Prior term birth, n (%) 0 14,810 (91.0) Prior preterm birth, n (%) 0 2,079 (12.8) Prior SAB, n (%) 9,777 (67.6) 6,181 (38.0) <.01 Autologous oocytes, n (%) 11,733 (81.1) 13,839 (85.1) <.01 Donor oocytes, n (%) 2,592 (17.9) 2,265 (13.9) <.01 Donor embryo, n (%) 151 (1.0) 169 (1.0) 1.00 Fresh embryo, n (%) 7,941 (54.9) 8,295 (51.0) <.01 Frozen embryo, n (%) 6,552 (45.3) 7,987 (49.1) <.01 No. of embryos transferred 2.13 2.12 n/a 2, n (%) 13,020 (90.0) 14,607 (89.8) .02 3, n (%) 1,141 (7.9) 1,377 (8.5) 4, n (%) 244 (1.7) 218 (1.3) ≥ 5, n (%) 65 (0.4) 64 (0.4) No.of fetal heartbeats 2.02 2.02 n/a 2, n (%) 14,164 (97.9) 15,968 (98.2) .20 3, n (%) 280 (1.9) 274 (1.7) 4, n (%) 26 (0.2) 24 (0.1) PGT all or some embryos, n (%) 1,496 (10.3) 1,507 (9.3) .002 Maternal ethnicity White, n (%) 6,580 (45.5) 7,897 (48.5) <.01 Asian, n (%) 1,153 (8.0) 919 (5.6) Hispanic, n (%) 686 (4.7) 939 (5.8) African American, n (%) 665 (4.6) 724 (4.5) American Indian Alaskan Native, n (%) 18 (0.1) 12 (0.1) Native Hawaii other pacific, n (%) 19 (0.1) 21 (0.1) Multiple, n (%) 216 (1.5) 180 (1.1) Unknown, n (%) 3,922 (27.1) 4,325 (26.6) Not Asked, n (%) 1,192 (8.2) 1,230 (7.6) Refused, n (%) 19 (0.1) 19 (0.1) Infertility diagnosis ‡ Male factor, n (%) 4,796 (33.1) 5,835 (35.9) <.01 Diminished ovarian reserve, n (%) 3,913 (27.0) 3,673 (22.6) <.01 Polycystic Ovary Syndrome, n (%) 2,454 (17.0) 2,791 (17.2) .64 Tubal factor, n (%) 2,111 (14.6) 3,034 (18.7) <.01 Ovulatory Disorder, n (%) 2,082 (14.4) 2,202 (13.5) .03 Unexplained infertility, n (%) 1,998 (13.8) 1,910 (11.7) <.01 Endometriosis, n (%) 1,369 (9.5) 1,396 (8.6) <.01 Uterine factor, n (%) 676 (4.7) 628 (3.9) <.01 Recurrent pregnancy loss, n (%) 133 (0.9) 100 (0.6) <.01 Other, n (%) 2,112 (14.6) 2,377 (14.6) .97 Note: Data are reported as mean, mean (SD), median [IQR], or n (%). P values are reported using t-test for normally distributed continuous data, Wilcoxon rank-sum test for nonnormally distributed continuous data, Fisher’s exact test for dichotomous and categorical data with fewer than five categories, and Chi-square test for categorical data with greater than five categories. BMI = body mass index; PGT = preimplantation genetic testing ∗ BMI data available for 82% of sample. † 93 instances of unknown fetal sex recorded as female/male. ‡ Since multiple diagnosis are recorded for some patients the sum of the percentages exceeds 100%.
Flow diagram of included and excluded cycles
Baseline demographic and clinical characteristics.
Note: Data are reported as mean, mean (SD), median [IQR], or n (%). P values are reported using t-test for normally distributed continuous data, Wilcoxon rank-sum test for nonnormally distributed continuous data, Fisher’s exact test for dichotomous and categorical data with fewer than five categories, and Chi-square test for categorical data with greater than five categories. BMI = body mass index; PGT = preimplantation genetic testing
BMI data available for 82% of sample.
93 instances of unknown fetal sex recorded as female/male.
Since multiple diagnosis are recorded for some patients the sum of the percentages exceeds 100%.
The gestational age at delivery and average birth weight were nonnormally distributed. The unadjusted analysis of outcomes was performed using Fisher’s exact test for categorical data and the Wilcoxon rank-sum test for continuous data. There were 93 instances of unknown fetal sex, and these were recorded as male/female because this was the most frequent combination.
Two logistic regression models were built, one for the rate of preterm delivery and the other for rate of low average birth weight (Stata version 16.1, StataCorp, College Station, TX). We used the methods described by Hosmer and Lemeshow for the purposeful selection of covariates ( 9 ). Demographic and clinical characteristics that differed ( P <.05) between nulliparous and parous groups were considered for evaluation as confounders. These characteristics included age, fetal sex, prior spontaneous abortion, use of autologous oocytes, use of one or more fresh embryos, the number of fetal heartbeats detected, use of preimplantation genetic testing, maternal ethnicity, and infertility diagnosis ( Table 1 ). Covariates that were independently associated with the outcomes of preterm delivery or low average birth weight in nulliparous women with a P < .20 (and an absolute difference of at least 1% between nulliparous and parous groups for ethnicity and infertility) were included in the preliminary model as shown in Supplemental Table 1 (available online). Age was included in the preliminary model for low birth weight although it was not statistically significant since a previous study has shown potential clinical significance ( 4 ). For both models, we used a number of fetal heartbeats in the model and omitted the number of embryos transferred because fetal heartbeats are more clinically significant and including both would introduce collinearity. The body mass index was excluded from both analyses because this data was only available for 82% of pregnancies and the difference between groups was not clinically significant.
The preliminary model consisted of all the variables identified on univariate analysis that differed between nulliparous and parous groups and were associated with preterm delivery or low birth weight in nulliparous patients. We then fit multivariable models (one model for preterm delivery and another model for low birth weight) containing all the identified variables and assessed the significance of each variable in the multivariable model. The final model was determined by removing variables that were insignificant in the multivariable model based on a P >.05 and no expected clinical significance.
For preterm delivery (before 37 weeks), there were no changes from the preliminary to the final model. All predictors were statistically significant except for the use of preimplantation genetic testing (PGT) and White ethnicity, which were left in the model because of potential clinical significance. The interaction between parity and age was not significant and was not included in the final model. The final model ( Table 2 and Supplemental Table 1 ) for preterm delivery included age as a continuous variable and the following as dichotomous variables: parous, use of autologous oocytes, use of one or more fresh embryos, the number of fetal heartbeats (2 or more than 2), use of PGT, White or not White, Asian or not Asian, and history of unexplained infertility. This same model was used in our secondary analysis to compare nulliparous, parous with a history of preterm delivery, and parous without a history of preterm delivery ( Table 3 ). We used this model to analyze delivery before 39 weeks, before 37 weeks, before 34 weeks, before 32 weeks, and before 28 weeks. Table 2 Primary analysis of obstetrical outcomes based on parity. Demographics and clinical characteristics Nulliparous (reference) n = 14,470 Parous n = 16,266 Rate difference (95% CI) OR (95% CI) Unadjusted P value Adjusted OR (95% CI) Adjusted P value Birth weight in grams (mean) 2344 (564) 2497 (533) Birth weight in grams (median) 2424 [2055, 2722] 2566 [2226, 2849] 4000g, n (%) 13 (0.1) 15 (0.1) 0.00 (-0.07-0.07) 1.03 (0.49-2.16) 1.00 1.12 (0.53-2.36) .77 Low birth weight, <2500g, n (%) 8,215 (56.8) 7,293 (44.8) 11.9 (10.8-13.0) 0.62 (0.59-0.65) < .01 0.63 (0.60-0.66) < .01 Very low birth weight, <1500g, n (%) 1,216 (8.4) 826 (5.1) 3.3 (2.8-3.9) 0.58 (0.53-0.64) < .01 0.58 (0.53-0.64) < .01 Gestational age in wk (mean) 35.5 (2.9) 35.9 (2.6) Gestational age in wk (median) 36.3 [34.4, 37.6] 36.6 [35.0, 37.6] < .01 Delivery before 39 wk, n (%) 14,170 (97.9) 15,938 (98.0) -0.06% (-0.37 to 0.26) 1.03 (0.88-1.21) .75 1.03 (0.88-1.21) .69 Delivery before 37 wk, n (%) 8,784 (60.7) 9,223 (56.7) 4.0 (2.9-5.1) 0.85 (0.81-0.89) < .01 0.86 (0.82-0.90) < .01 Delivery before 34 wk, n (%) 2,934 (20.3) 2,504 (15.4) 4.9 (4.0%-5.7) 0.72 (0.67-0.76) < .01 0.73 (0.68-0.77) < .01 Delivery before 32 wk, n (%) 1,482 (10.2) 1,138 (7.0) 3.2 (2.6%-3.9) 0.66 (0.61-0.71) < .01 0.67 (0.62-0.73) < .01 Delivery before 28 wk, n (%) 477 (3.3) 340 (2.1) 1.2 (0.8-1.6) 0.63 (0.54-0.72) < .01 0.63 (0.55-0.73) < .01 Note: Data are reported as mean (SD), median [IQR] or n (%). Unadjusted P values are reported using the Wilcoxon rank-sum test for nonnormally distributed continuous data and Fisher’s exact test for dichotomous data. Adjusted P values are reported using logistic regression. Table 3 Secondary analysis of obstetrical outcomes based on parity and history of preterm birth. Demographics and clinical characteristics Group 1 nulliparous n = 14,470 Group 2 parous with prior preterm birth n = 2,079 Group 3 parous without prior preterm birth n = 14,187 P value Groups 1 and 2 Adjusted P value group 1 vs 2 P value group 1 vs 3 Adjusted P value group 1 vs 3 P value group 2 vs 3 Adjusted P value group 2 vs 3 Birth weight in grams (mean) 2344 (564) 2346 (579) 2519 (523) Birth weight in grams (median) 2424 [2055, 2722] 2424 [2041, 2736] 2580 [2254, 2863] .79 < .01 4000g, n (%) 13 (0.1) 1 (0.0) 14 (0.1) 1.00 .68 .85 .66 .71 .52 Low birth weight, <2500g, n (%) 8,215 (56.8) 1,162 (55.9) 6,131 (43.2) .45 .91 < .01 < .01 < .01 < .01 Very low birth weight, <1500g, n (%) 1,216 (8.4) 175 (8.4) 651 (4.6) .97 .96 < .01 < .01 < .01 < .01 Gestational age in wk (mean) 35.5 (2.9) 35.1 (2.9) 36.0 (2.5) Gestational age in wk (median) 36.3 [34.4, 37.6] 35.9 [34.0, 37.1] 36.7 [35.1, 37.7] < .01 < .01 < .01 Delivery before 39 wk , n (%) 14,170 (97.9) 2,051 (98.7) 13,887 (97.9) .03 .04 .84 .86 .02 .02 Delivery before 37 wk , n (%) 8,784 (60.7) 1,448 (69.6) 7,775 (54.8) < .01 < .01 < .01 < .01 < .01 < .01 Delivery before 34 wk , n (%) 2,934 (20.3) 509 (24.5) 1,995 (14.1) < .01 < .01 < .01 < .01 < .01 < .01 Delivery before 32 wk , n (%) 1,482 (10.2) 246 (11.8) 892 (6.3) .03 .02 < .01 < .01 < .01 < .01 Delivery before 28 wk , n (%) 477 (3.3) 83 (4.0) 257 (1.8) .10 .08 < .01 < .01 < .01 < .01 N ote: Data are reported as mean (SD), median [IQR] or n (%). Unadjusted P values are reported using the Wilcoxon rank-sum test for nonnormally distributed continuous data and Fisher’s exact test for dichotomous data. Adjusted P values are reported using logistic regression.
Primary analysis of obstetrical outcomes based on parity.
Note: Data are reported as mean (SD), median [IQR] or n (%). Unadjusted P values are reported using the Wilcoxon rank-sum test for nonnormally distributed continuous data and Fisher’s exact test for dichotomous data. Adjusted P values are reported using logistic regression.
Secondary analysis of obstetrical outcomes based on parity and history of preterm birth.
N ote: Data are reported as mean (SD), median [IQR] or n (%). Unadjusted P values are reported using the Wilcoxon rank-sum test for nonnormally distributed continuous data and Fisher’s exact test for dichotomous data. Adjusted P values are reported using logistic regression.
For low average birth weight (< 2500 grams), there were also no changes from the preliminary to the final model. All predictors were statistically significant except for the use of PGT, diminished ovarian reserve, and unexplained infertility. These were left in the model because of potential clinical significance. The interaction between parity and age was not significant and was not included in the final model. The final model ( Table 2 and Supplemental Table 1 ) for low average birth weight included age as a continuous variable and the number of male fetuses (0, 1, or 2) as an ordinal variable. The following dichotomous variables were included: parous, use of autologous oocytes, use of one or more fresh embryos, the number of fetal heartbeats (2 or more than 2), use of PGT, White or not White, Asian or not Asian, male factor infertility, diminished ovarian reserve, tubal factor, and unexplained infertility. This same model was used in our secondary analysis of parity ( Table 3 ). We used this model for the analysis of average fetal weight (assessed as > 4000 grams, < 2500 grams, and < 1500 grams).
Hosmer and Lemeshow overall goodness of fit tests did not show evidence of poor fit for predicting the risk of preterm delivery ( P =.16) or low average birth weight ( P = .24). A P <.01 was considered statistically significant for comparisons of outcomes between nulliparous and parous groups.